Viatris | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Adcock Ingram Holdings ZAR 79.14M 10.28M 2024-12
Celltrion KRW 829.07B 783.59B 2025-03
Cspc Pharmaceutical 8.37B 3.64B 2024-06
Dianthus Therapeutics USD 22.79M 10.88M 2024-12
Divis Laboratories Ltd 4.15B 31.87B 2025-03
Kangmei Pharma CNY 773.51M 28.83M 2024-09
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 27.19M 17.39M 2024-12
Malin Corporation EUR 35.7M 6.4M 2024-06
Medical Developments International AUD 9.74M 5.96M 2024-06
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Pharma Mar EUR 60.29M 2.95M 2025-03
Qiagen NV USD 663.56M 309.42M 2024-12
Sartorius EUR 839.5M 26.1M 2025-03
Sino Biopharmaceutical CNY 8.55B 902.41M 2024-06
Tilray USD 189.7M 15.49M 2024-11
Viatris USD 755M 20.2M 2025-03
Zz Pientze Pharmaceu 1.39B 93.82M 2025-03



Viatris Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.